Michael Buhle

Chief Executive Officer at Aspira Women's Health.

Austin, TX
Form D signer
Aspira Women's Health

Raised on Aspira Women's Health filings

$5.8M

of $5.8M offered across 3 Form D filings

Form D filings: 3
Teammates: 3
Last filing: Jun 22, 2026

Company

Aspira Women's Health

Biotech · Austin, TX

Blood tests for ovarian cancer risk

Blood tests for ovarian cancer risk

Investors: 27

Investors: 27
Sector: Biotech
HQ: Austin, TX

Aspira Women's Health filings

Aspira Women's Health Form D filings
Filed	Security	Sold of offered	Filing
Jun 22, 2026	Equity	$1.5M/ $1.5M	Form D
Sep 18, 2025	Equity	$3M/ $3M	Form D
Mar 20, 2025	Equity	$1.4M/ $1.4M	Form D

EquityFiled Jun 22, 2026Form D
$1.5M/ $1.5M
EquityFiled Sep 18, 2025Form D
$3M/ $3M
EquityFiled Mar 20, 2025Form D
$1.4M/ $1.4M

Works with

Also named on Aspira Women's Health filings

John StrahleyChief Financial Officer, Form D signerForm D signer Ellen BeausangDirector Winfred ParnellDirector